Management of Levetiracetam (Keppra) Overdose
For levetiracetam overdose, provide supportive care with airway protection, consider hemodialysis for severe cases or significant renal impairment, and monitor for CNS depression, respiratory depression, and cardiovascular toxicity. 1
Immediate Management
Supportive Care (Primary Approach)
There is no specific antidote for levetiracetam overdose 1. Management centers on:
- Airway management: Intubation may be required for obtundation and respiratory depression 2
- Gastric decontamination: If presenting early, consider emesis or gastric lavage with appropriate airway precautions 1
- Vital sign monitoring: Watch for bradycardia, hypotension, and respiratory compromise 3
- Contact Poison Control: For up-to-date management guidance 1
Expected Clinical Presentation
The severity of overdose manifestations varies considerably:
Common findings include:
- Somnolence and CNS depression (most frequent) 1, 2
- Respiratory depression requiring intubation 2
- Agitation and aggression 1
- Depressed level of consciousness progressing to coma 1
Cardiovascular toxicity (less common but significant):
- Bradycardia and hypotension responsive to atropine and IV fluids 3
- The mechanism appears to involve muscarinic receptor effects at high concentrations, as echocardiography shows normal ventricular function 3
Renal complications (rare but serious):
- Acute kidney injury with oliguria may develop 4
- Monitor creatinine and urine output closely
Hemodialysis Considerations
Hemodialysis removes approximately 50% of levetiracetam in 4 hours and should be strongly considered in specific situations 1:
Clear Indications for Hemodialysis:
- Severe overdose with significant clinical toxicity
- Patients with significant renal impairment 1
- Development of acute kidney injury 4
- Persistent severe CNS or respiratory depression despite supportive care
The case literature demonstrates hemodialysis is beneficial when acute renal failure develops, with successful recovery after dialysis initiation 4.
Pharmacokinetic Considerations
Understanding levetiracetam kinetics in overdose helps predict clinical course:
- Elimination half-life in overdose: Approximately 5-10 hours 2, 3
- Peak concentrations: Reported up to 463 mcg/mL (therapeutic range 10-40 mcg/mL) 3
- Elimination pattern: First-order kinetics maintained even at concentrations 10-40 fold above therapeutic 2
- Recovery timeline: Most patients recover within 24-48 hours with supportive care 3, 2
Monitoring Parameters
Track these specific parameters:
- Neurological status: Level of consciousness, respiratory effort
- Cardiovascular: Heart rate, blood pressure (hypotension and bradycardia may occur)
- Renal function: Creatinine, urine output (oliguria signals potential AKI)
- Deep tendon reflexes: May be diminished 2
Prognosis and Recovery
The prognosis is generally excellent with appropriate supportive care. Most patients recover completely without sequelae within 24-48 hours 5, 6, 2. Even massive overdoses (>22,500 mg or 358 mg/kg) have resulted in minimal symptoms 6. However, clinical vigilance remains essential as severe cases requiring intubation have been documented 2.
Critical Pitfalls to Avoid:
- Underestimating renal complications: While rare, acute kidney injury can develop and requires dialysis 4
- Dismissing cardiovascular effects: Bradycardia and hypotension can occur and may respond to atropine 3
- Premature discharge: Observe for at least 24 hours given the elimination half-life and potential for delayed complications